BioInnovation Institute

The BioInnovation Institute (BII) operates as an international commercial foundation dedicated to accelerating research and startups within the life sciences. It functions as an incubator that translates bold scientific ideas into innovative products and solutions, specifically addressing significant challenges in human, planetary, and environmental health. Through various programs, BII provides strategic guidance and resources to foster the development and commercialization of new scientific ventures.

The BioInnovation Institute was established in December 2017 by the Novo Nordisk Foundation. This initiative stemmed from an insight that local life science research and innovation required dedicated support to bridge the gap between academic discoveries and market-ready enterprises. The Foundation leveraged its significant resources and vision to create a robust ecosystem for advancing entrepreneurship in the biomedical, bioindustrial, and environmental fields.

BII primarily serves academic researchers and nascent life science startups, particularly within the Danish innovation ecosystem, aiming to bolster their journey from concept to commercial viability. The institute's overarching mission is to cultivate an environment where impactful scientific breakthroughs can rapidly evolve into tangible solutions, ultimately contributing to a healthier future for both people and the planet.